Cortexyme Inc (CRTX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

269 EAST GRAND AVE SOUTH SAN FRANCISCO, CA 94080

Cortexyme, Inc. operates as a biotech company. The Company develops therapeutics and diagnostics for the treatment of alzheimer disease and other neurodegenerative disorders. Cortexyme serves clients in the State of California.

Data as of 2020-08-09
Market Cap1.298 Billion Shares Outstanding29.417 Million Avg 30-day Volume96.478 Thousand
P/E Ratio Dividend Yield EPS-1.9
Price/Sales Price cash flow ratio Price free cash flow ratio-42.5
Book Value7.41 Price to Tangible Book5.95 Alpha0.07
Short Interest Ratio % Short Interest to Float R-squared0.055257
BETA1.51796 52-week High/Low73.84 / 19.35 Stddev0.383813

Are you looking for this stock instead?

View SEC Filings from CRTX instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 1 0 (0.0%)
13F Filers holding this stock: 67 14 (0.92%)
Aggregate 13F shares on 03/31/2020: 8.067 Million 1.018 Million
Aggregate 13F shares on 12/31/2019: 7.256 Million 663.818 Thousand
Percent change: 11.18% 53.30%
Funds creating new positions: 18 6
Funds Adding to an existing position: 26 4
Funds closing out their position: 2 1
Funds reducing their position: 14 2
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CRTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CRTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

9 Thousand total shares from 2 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

EPIQ CAPITAL GROUP, LLC

BOEDING CHAD

  • IA/MANAGING MEMBER OF 10% OWNEMANAGING MEMBER OF MANAGING ME
2,860,967 2020-06-11 1

LAMOND DAVID

  • Director
986,019 2020-06-09 4

RYAN UNA S

  • Director
0 2020-06-08 1

YOUNG KEVIN

  • Director
0 2020-06-08 1

MCLOUGHLIN MARGARET

  • Director
0 2020-06-08 1

SENNER CHRISTOPHER J.

  • Director
0 2020-06-08 1

PFIZER INC

PFIZER STRATEGIC INVESTMENT HOLDINGS LLC

PFIZER VENTURES (US) LLC

  • 10% Owner
2,879,973 2020-06-03 1

DETKE MICHAEL J. CHIEF MEDICAL OFFICER

  • Officer
28,261 2020-05-27 3

HOLSINGER LESLIE EXECUTIVE VICE PRESIDENT

  • Officer
0 2020-05-14 2

LOWE CHRISTOPHER P. CHIEF FINANCIAL OFFICER

  • Officer
0 2020-05-14 2

MCDOWELL CARYN GORDON CHIEF LEGAL & ADM. OFFICER

  • Officer
0 2020-05-14 2

GAFRIC KRISTEN SVP, LEGAL & ADMINISTRATION

  • Officer
0 2020-02-06 1

DOMINY STEPHEN S. CHIEF SCIENTIFIC OFFICER

  • Officer
  • Director
0 2020-02-06 1

LYNCH CASEY CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2020-02-06 1

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

EPIQ CAPITAL GROUP, LLC IA/MANAGING MEMBER OF 10% OWNE by mr. boeding as trustee of the boeding family trust

BOEDING CHAD MANAGING MEMBER OF MANAGING ME by mr. boeding as trustee of the boeding family trust

2020-06-12 P 2,440 $44.06 a 2,860,967 2,860,967.00 indirect

EPIQ CAPITAL GROUP, LLC IA/MANAGING MEMBER OF 10% OWNE by mr. boeding as trustee of the boeding family trust

BOEDING CHAD MANAGING MEMBER OF MANAGING ME by mr. boeding as trustee of the boeding family trust

2020-06-11 P 6,600 $44.32 a 2,858,527 2,860,967.00 indirect
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments